Alteration of the EphA2/Ephrin-a signaling axis in psoriatic epidermis

Journal of Investigative Dermatology

Volumn 133, Issue 3, 2013, Pages 712-722

  Gordon, Kristin ^a   Kochkodan, James J ^b   Blatt, Hanz ^a   Lin, Samantha Y ^a   Kaplan, Nihal ^a   Johnston, Andrew ^b   Swindell, William R ^c   Hoover, Paul ^a   Schlosser, Bethanee J ^a   Elder, James T ^b,d   Gudjonsson, Johann E ^b   Getsios, Spiro ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EPHRIN A1; EPHRIN A4; EPHRIN RECEPTOR A2; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1ALPHA; MESSENGER RNA; PSORIASIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BIOPSY; UPREGULATION;

EID: 84873737067     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.391     Document Type: Article

References (58)

1. Banno T, Gazel A, Blumenberg M (2004) Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279: 32633-42
2. Barrientos S, Stojadinovic O, Golinko MS et al. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601
3. Batlle E, Wilkinson DG (2012) Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis. Cold Spring Harb Perspect Biol 4: a008227
4. Beauchamp A, Debinski W (2012) Ephs and ephrins in cancer: ephrin-A1 signalling. Semin Cell Dev Biol 23: 109-15
5. Chan JR, Blumenschein W, Murphy E et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203: 2577-87
6. Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M et al. (2011) Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-87
7. Denning MF, Wang Y, Tibudan S et al. (2002) Caspase activation and disruption of mitochondrial membrane potential during UV radiationinduced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ 9: 40-52
8. Di Meglio P, Perera GK, Nestle FO (2011) The multitasking organ: recent insights into skin immune function. Immunity 35: 857-69
9. Egawa G, Osawa M, Uemura A et al. (2009) Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol 129: 2386-95
10. Elder JT, Astrom A, Pettersson U et al. (1992) Retinoic acid receptors and binding proteins in human skin. J Invest Dermatol 98: 36S-41S
11. Elder JT, Bruce AT, Gudjonsson JE et al. (2010) Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 130: 1213-26
12. Eph Nomenclature Committee (1997) Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell 90: 403-4
13. Funk SD, Yurdagul A Jr, Albert P et al. (2012) EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol 32: 686-95
14. Genander M, Holmberg J, Frisen J (2010) Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells 28: 1196-205
15. Getsios S, Simpson CL, Kojima S et al. (2009) Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 185: 1243-58
16. Gudjonsson JE, Ding J, Johnston A et al. (2010a) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130: 1829-40
17. Gudjonsson JE, Johnston A, Stoll SW et al. (2010b) Evidence for altered Wnt signaling in psoriatic skin. J Invest Dermatol 130: 1849-59
18. Guo H, Miao H, Gerber L et al. (2006) Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 66: 7050-8
19. Gutowska-Owsiak D, Ogg GS (2012) The epidermis as an adjuvant. J Invest Dermatol 132: 940-8
20. Guttman-Yassky E, Nograles KE, Krueger JG (2011) Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J Allergy Clin Immunol 127: 1110-8
21. Haase I, Hobbs RM, Romero MR et al. (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108: 527-36
22. Hafner C, Becker B, Landthaler M et al. (2006) Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 19: 1369-77
23. Holzman LB, Marks RM, Dixit VM (1990) A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol 10: 5830-8
24. Irie F, Okuno M, Matsumoto K et al. (2008) Heparan sulfate regulates ephrin-A3/EphA receptor signaling. Proc Natl Acad Sci USA 105: 12307-12
25. Ivanov AI, Steiner AA, Scheck AC et al. (2005) Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats. Physiol Genomics 21: 152-60
26. Jabbari A, Suarez-Farinas M, Dewell S et al. (2012) Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes. J Invest Dermatol 132: 246-9
27. Johnston A, Gudjonsson JE, Aphale A et al. (2011a) EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. J Invest Dermatol 131: 329-37
28. Johnston A, Xing X, Guzman AM et al. (2011b) IL-1F5,-F6,-F8, and-F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186: 2613-22
29. Kaplan N, Fatima A, Peng H et al. (2012) EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration. Invest Ophthalmol Vis Sci 53: 936-45
30. Kulski JK, Kenworthy W, Bellgard M et al. (2005) Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med (Berl) 83: 964-75
31. Lackmann M, Boyd AW (2008) Eph, a protein family coming of age: more confusion, insight, or complexity?. Sci Signal 1: re2
32. Larsen AB, Pedersen MW, Stockhausen MT et al. (2007) Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res 5: 283-93
33. Leigh IM, Pulford KA, Ramaekers FC et al. (1985) Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol 113: 53-64
34. Lin S, Gordon K, Kaplan N et al. (2010) Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1. Mol Biol Cell 21: 3902-14
35. Lin S, Wang B, Getsios S (2012) Eph/ephrin signaling in epidermal differentiation and disease. Semin Cell Dev Biol 23: 92-101
36. Macrae M, Neve RM, Rodriguez-Viciana P et al. (2005) A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8: 111-8
37. Madsen P, Rasmussen HH, Leffers H et al. (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 97: 701-12
38. Marikovsky M, Breuing K, Liu PY et al. (1993) Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90: 3889-93
39. Mee JB, Johnson CM, Morar N et al. (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171: 32-42
40. Miao H, Li DQ, Mukherjee A et al. (2009) EphA2 mediates liganddependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16: 9-20
41. Miao H, Wang B (2009) Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol 41: 762-70
42. Miao H, Wang B (2012) EphA receptor signaling-complexity and emerging themes. Semin Cell Dev Biol 23: 16-25
43. Miao H, Wei BR, Peehl DM et al. (2001) Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 3: 527-30
44. Minner F, Poumay Y (2009) Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J Invest Dermatol 129: 770-3
45. Pasquale EB (2005) Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6: 462-75
46. Piruzian ES, Ishkin AA, Nikol'skaia TA et al. (2009) [The comparative analysis of psoriasis and Crohn disease molecular-genetical processes under pathological conditions]. Mol Biol (Mosk) 43: 175-9
47. Simpson CL, Kojima S, Getsios S (2010) RNA interference in keratinocytes and an organotypic model of human epidermis. Methods Mol Biol 585: 127-46
48. Swamy M, Jamora C, Havran W et al. (2010) Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol 11: 656-65
49. Takahashi H, Ibe M, Nakamura S et al. (2002) Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci 30: 94-9
50. Tjabringa G, Bergers M, van Rens D et al. (2008) Development and validation of human psoriatic skin equivalents. Am J Pathol 173: 815-23
51. Tschachler E (2007) Psoriasis: the epidermal component. Clin Dermatol 25: 589-95
52. Walsh R, Blumenberg M (2011) Specific and shared targets of ephrin A signaling in epidermal keratinocytes. J Biol Chem 286: 9419-28
53. Walsh R, Blumenberg M (2012) EPH-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes. J Cell Physiol 227: 2330-40
54. Weinstein GD, McCullough JL, Ross PA (1985) Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 85: 579-83
55. Wykosky J, Gibo DM, Debinski W (2007) A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells. Mol Cancer Ther 6: 3208-18
56. Yamada Y, Midorikawa T, Oura H et al. (2008) Ephrin-A3 not only increases the density of hair follicles but also accelerates anagen development in neonatal mice. J Dermatol Sci 52: 178-85
57. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204: 3183-94
58. Zhang G, Njauw CN, Park JM et al. (2008) EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res 68: 1691-6